Rheumatoid arthritis treated with implanted cells that release drug
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Arthritis | Genetics | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology | Washington University